Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells

World Journal of Gastroenterology

Volumn 18, Issue 31, 2012, Pages 4199-4206

  Chai, Ning Li ^a   Fu, Qiang ^b   Shi, Hui ^a   Cai, Chang Hao ^a   Wan, Jun ^a   Xu, Shi Ping ^a   Wu, Ben Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Xi'an Children's Hospital   (China)

Author keywords

Arg Gly Asp peptide; Hepatic fibrosis; Hepatic stellate cell; Oxymatrine; Target therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; ARGINYLGLYCYLASPARTIC ACID; CARBON TETRACHLORIDE; EOSIN; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; HEMATOXYLIN; LIPOSOME; OXYMATRINE; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TYPE I PROCOLLAGEN; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG FORMULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; LIVER FIBROSIS; LIVER INJURY; MASSON STAINING; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; STELLATE CELL;

EID: 84867694572     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i31.4199     Document Type: Article

References (37)

1. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
2. Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 2011; 193: 225-231
3. Kastanis GJ, Hernandez-Nazara Z, Nieto N, Rincón-Sanchez AR, Popratiloff A, Dominguez-Rosales JA, Lechuga CG, Rojkind M. The role of dystroglycan in PDGF-BB-dependent migration of activated hepatic stellate cells/myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2011; 301: G464-G474
4. Kim MR, Kim HS, Lee MS, Lee MJ, Jang JJ. Cell cycle protein profile of the hepatic stellate cells(HSCs)in dimethylnitrosamine-induced rat hepatic fibrosis. Exp Mol Med 2005; 37: 335-342
5. Zhang Y, Liu P, Gao X, Qian W, Xu K. rAAV2-TGF-β(3) decreases collagen synthesis and deposition in the liver of experimental hepatic fibrosis rat. Dig Dis Sci 2010; 55: 2821-2830
6. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-1199
7. Rosenberg P, Sjöström M, Söderberg C, Kinnman N, Stål P, Hultcrantz R. Attenuated liver fibrosis after bile duct ligation and defective hepatic stellate cell activation in neural cell adhesion molecule knockout mice. Liver Int 2011; 31: 630-641
8. Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol 2011; 137: 714-723
9. Wang YP, Zhao W, Xue R, Zhou ZX, Liu F, Han YX, Ren G, Peng ZG, Cen S, Chen HS, Li YH, Jiang JD. Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antiviral Res 2011; 89: 227-231
10. Wu XN, Wang GJ. Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections. Chin J Dig Dis 2004; 5: 12-16
11. Chen XS, Wang GJ, Cai X, Yu HY, Hu YP. Inhibition of hepatitis B virus by oxymatrine in vivo. World J Gastroenterol 2001; 7: 49-52
12. Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang B, Zheng S. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res 2011; 30: 66
13. Du SL, Pan H, Lu WY, Wang J, Wu J, Wang JY. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats. J Pharmacol Exp Ther 2007; 322: 560-568
14. Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003; 91: 115-122
15. Li Q, Yan Z, Li F, Lu W, Wang J, Guo C. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells. Nanotechnology 2012; 23: 265101
16. Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology 2011; 141: 900-908. e1-2
17. Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955-975
18. Ricchi P, Lanza AG, Ammirabile M, Costantini S, Cinque P, Spasiano A, Di Matola T, Di Costanzo GG, Pagano L, Prossomariti L. Hepatitis C virus distribution and clearance following interferon-monotherapy among thalassaemia major and intermedia patients. Br J Haematol 2011; 155: 524-527
19. Fallowfield J, Hayes P. Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? Clin Med 2011; 11: 179-183
20. Lin M, Yang LY, Li WY, Peng YP, Zheng JK. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. J Int Med Res 2009; 37: 1411-1419
21. Lu LG, Zeng MD, Mao YM, Li JQ, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX, Zhang HQ. Oxymatrine therapy for chronic hepatitis B: a randomized doubleblind and placebo-controlled multi-center trial. World J Gastroenterol 2003; 9: 2480-2483
22. Shi GF, Li Q, Weng XH, Wu XH. [Effects of Oxymatrine on the expression of tissue inhibitor of metalloproteinase-1 and alpha-smooth muscle actin in the livers of rats with hepatic fibrosis]. Zhonghua Gan Zang Bing Zazhi 2004; 12: 56
23. Yang W, Zeng M, Fan Z, Mao Y, Song Y, Jia Y, Lu L, Chen CW, Peng YS, Zhu HY. [Prophylactic and therapeutic effect of oxymatrine on D-galactosamine-induced rat liver fibrosis]. Zhonghua Gan Zang Bing Zazhi 2002; 10: 193-196
24. Deng ZY, Li J, Jin Y, Chen XL, Lü XW. Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis. Chin Med J (Engl) 2009; 122: 1449-1454
25. Wu XL, Zeng WZ, Jiang MD, Qin JP, Xu H. Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 2008; 14: 2100-2105
26. Shen BS, Song XW. [Effects of oxymatrine on serum cytokines and hepatic fibrotic indexes in patients with chronic hepatitis B]. Zhongguo Zhong Xi Yi Jie He Zazhi 2008; 28: 17-19
27. Xiang X, Wang G, Cai X, Li Y. Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. Chin Med J (Engl) 2002; 115: 593-596
28. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007; 131: 1728-1734
29. Reeves HL, Friedman SL. Activation of hepatic stellate cells--a key issue in liver fibrosis. Front Biosci 2002; 7: d808-d826
30. Kisseleva T, Brenner DA. Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol 2006; 21 Suppl 3: S84-S87
31. Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 2008; 376: 271-276
32. Shi GF, Li Q. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World J Gastroenterol 2005; 11: 268-271
33. Li J, Fan R, Zhao S, Liu L, Guo S, Wu N, Zhang W, Chen P. Reactive Oxygen Species Released from Hypoxic Hepatocytes Regulates MMP-2 Expression in Hepatic Stellate Cells. Int J Mol Sci 2011; 12: 2434-2447
34. Hasegawa-Baba Y, Doi K. Changes in TIMP-1 and-2 expression in the early stage of porcine serum-induced liver fibrosis in rats. Exp Toxicol Pathol 2011; 63: 357-361
35. Chen MH, Wang QF, Chen LG, Shee JJ, Chen JC, Chen KY, Chen SH, Su JG, Liu YW. The inhibitory effect of Gynostemma pentaphyllum on MCP-1 and type I procollagen expression in rat hepatic stellate cells. J Ethnopharmacol 2009; 126: 42-49
36. Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, Meijer DK, Poelstra K. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology 1999; 29: 1486-1493
37. Beljaars L, Molema G, Schuppan D, Geerts A, De Bleser PJ, Weert B, Meijer DK, Poelstra K. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J Biol Chem 2000; 275: 12743-12751